This nomogram serves as a simple and effective tool for early prediction of therapeutic efficacy in patients with advanced gastric cancer receiving PD-1 inhibitor-combined chemotherapy, thereby aiding clinicians in formulating personalized treatment plans. Here, PDCD1 is linked to gastric cancer.